國立高雄大學圖資館 |

Language: English

Back

Kala Azar in South Asiacurrent statu...

Jha, T.K.

Kala Azar in South Asiacurrent status and sustainable challenges /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Kala Azar in South Asiaedited by Eisei Noiri, T.K. Jha.
Reminder of title:	current status and sustainable challenges /
other author:	Noiri, Eisei.
Published:	Cham :Springer International Publishing :2016.
Description:	xx, 309 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Kala-azarSouth Asia.
Online resource:	http://dx.doi.org/10.1007/978-3-319-47101-3
ISBN:	9783319471013$q(electronic bk.)

Kala Azar in South Asiacurrent status and sustainable challenges /
Kala Azar in South Asiacurrent status and sustainable challenges /[electronic resource] :edited by Eisei Noiri, T.K. Jha. - Cham :Springer International Publishing :2016. - xx, 309 p. :ill., digital ;24 cm.

Preface. Part I Introduction into Kala-Azar Pathology and Mechanism of Disease in Kala-Azar -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Characteristics of Patients Visiting Suruya Kanta Kala-Azar Research Center in Mymensingh, Bangladesh; Data from a Patient Registry System -- Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries -- Part II Therapeutic Strategy to Deal with Emergence of Drug Resistance -- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Combination Therapy for Leishmaniasis -- Vaccine Development for Leishmaniasis -- Siccanin is a novel selective inhibitor of trypanosomatid complex II (succinate-ubiquinone reductase) and a potent broad-spectrum anti-trypanosomatid drug candidate -- Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent -- Part III Diagnostic Strategy Enhancing Kala-Azar Elimination Program -- Changes of Leishmania antigens in kala-azar patients' urine after treatment -- Potentiality of Urinary L-FABP Tests to Kala-azar Disease Management -- Antibody Capture Direct Agglutination Test (abcDAT) for Diagnosis of Visceral Leishmaniasis with Urine -- Loop-mediated Isothermal Amplification (LAMP): Molecular Diagnosis for the Field Survey of Visceral Leishmaniasis -- Applicability of Multiplex Real-Time PCR to Visceral Leishmaniasis -- Immunoglobulins in the Pathophysiology of Visceral Leishmaniasis -- Part V Knowledge and Practice for Vector Control in Kala-Azar -- Geographical Distribution and Ecological Aspect of Sand Fly Species in Bangladesh -- The efficacy of long lasting insecticidal nets for leishmaniasis in Asia -- Environmental change and kala-azar with particular reference to Bangladesh -- Part VI. New Challenges in the Kala-azar Elimination Programme -- Drug Safety Monitoring for Liposomal Amphotericin B -- Resolution Mapping of Kala-azar Hot Spots Using GPS Logger and Urinary Antibody Measurements -- Geography and Reality of Kala-azar Endemic in Bangladesh, Analysis Using GIS and Urine-based Mass Screening -- Animal Models of Visceral Leishmaniasis and Applicability to Disease Control -- Pharmacovigilance on Therapeutic Protocols for Visceral Leishmaniasis. Index.

ISBN: 9783319471013$q(electronic bk.)

Standard No.: 10.1007/978-3-319-47101-3doiSubjects--Topical Terms:

510464
Kala-azar
--South Asia.

LC Class. No.: RC152

Dewey Class. No.: 616.9364

Kala Azar in South Asiacurrent status and sustainable challenges /
LDR:03240nmm a2200301 a 4500 001 502327
003 DE-He213
005 20170112135242.0
006 m d
007 cr nn 008maaau
008 170823s2016 gw s 0 eng d
020 $a 9783319471013$q(electronic bk.)
020 $a 9783319436111$q(paper)
024 7 $a 10.1007/978-3-319-47101-3 $2 doi
035 $a 978-3-319-47101-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC152
072 7 $a MMFP $2 bicssc
072 7 $a MED103000 $2 bisacsh
082 0 4 $a 616.9364 $2 23
090 $a RC152 $b .K14 2016
245 0 0 $a Kala Azar in South Asia $h [electronic resource] : $b current status and sustainable challenges / $c edited by Eisei Noiri, T.K. Jha.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xx, 309 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface. Part I Introduction into Kala-Azar Pathology and Mechanism of Disease in Kala-Azar -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Characteristics of Patients Visiting Suruya Kanta Kala-Azar Research Center in Mymensingh, Bangladesh; Data from a Patient Registry System -- Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries -- Part II Therapeutic Strategy to Deal with Emergence of Drug Resistance -- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Combination Therapy for Leishmaniasis -- Vaccine Development for Leishmaniasis -- Siccanin is a novel selective inhibitor of trypanosomatid complex II (succinate-ubiquinone reductase) and a potent broad-spectrum anti-trypanosomatid drug candidate -- Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent -- Part III Diagnostic Strategy Enhancing Kala-Azar Elimination Program -- Changes of Leishmania antigens in kala-azar patients' urine after treatment -- Potentiality of Urinary L-FABP Tests to Kala-azar Disease Management -- Antibody Capture Direct Agglutination Test (abcDAT) for Diagnosis of Visceral Leishmaniasis with Urine -- Loop-mediated Isothermal Amplification (LAMP): Molecular Diagnosis for the Field Survey of Visceral Leishmaniasis -- Applicability of Multiplex Real-Time PCR to Visceral Leishmaniasis -- Immunoglobulins in the Pathophysiology of Visceral Leishmaniasis -- Part V Knowledge and Practice for Vector Control in Kala-Azar -- Geographical Distribution and Ecological Aspect of Sand Fly Species in Bangladesh -- The efficacy of long lasting insecticidal nets for leishmaniasis in Asia -- Environmental change and kala-azar with particular reference to Bangladesh -- Part VI. New Challenges in the Kala-azar Elimination Programme -- Drug Safety Monitoring for Liposomal Amphotericin B -- Resolution Mapping of Kala-azar Hot Spots Using GPS Logger and Urinary Antibody Measurements -- Geography and Reality of Kala-azar Endemic in Bangladesh, Analysis Using GIS and Urine-based Mass Screening -- Animal Models of Visceral Leishmaniasis and Applicability to Disease Control -- Pharmacovigilance on Therapeutic Protocols for Visceral Leishmaniasis. Index.
650 0 $a Kala-azar $z South Asia. $3 510464
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Parasitology. $3 194533
650 2 4 $a Drug Resistance. $3 338425
650 2 4 $a Veterinary Medicine/Veterinary Science. $3 761093
650 2 4 $a Laboratory Medicine. $3 276727
650 2 4 $a Nephrology. $3 274884
700 1 $a Noiri, Eisei. $3 677580
700 1 $a Jha, T.K. $3 510462
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-47101-3
950 $a Biomedical and Life Sciences (Springer-11642)